Dr. Brown is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9548 Park Meadows Dr
Lone Tree, CO 80124Phone+1 720-848-2200Fax+1 720-553-0901
Summary
- A member of the University of Colorado Cancer Center. We provide advanced cancer care close to home. Patients have access to clinical trials at our Lone Tree location. We have a wonderful team of healthcare professionals that provide multidisciplinary care.
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2003 - 2006
- MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2000 - 2003
- Saint Louis University School of MedicineClass of 2000, MD, Distinction in Research
- United States Air Force AcademyBS, Science, 1981 - 1985
- United States Air Force AcademyBS, 1981 - 1985
Certifications & Licensure
- CO State Medical License 2006 - 2025
- DC State Medical License 2006 - 2024
- WY State Medical License 2013 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Ray of Hope Honoree Ray of Hope Foundation, 2018
- Honoree Ray of Hope Cancer Foundation, 2018
- The Pearl M. Stetler Research Fund Award 2006
- Join now to see all
Clinical Trials
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer Start of enrollment: 2009 Jul 15
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsPlasma and Urine Metabolite Profiles Impacted by Increased Dietary Navy Bean Intake in Colorectal Cancer Survivors: A Randomized-Controlled TrialIman Zarei, Bridget A. Baxter, Renee C Oppel, Erica C. Borresen, Regina J. Brown
Cancer Prevention Research. 2021-04-01 - 17 citationsModulation of plasma and urine metabolome in colorectal cancer survivors consuming rice branIman Zarei, Renee C Oppel, Erica C. Borresen, Regina J. Brown, Elizabeth P. Ryan
Integrative Food, Nutrition and Metabolism. 2019-04-05 - A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer.Ericson Stoen, Peter Kabos, Kelly C Borden, Regina J. Brown, Virginia F. Borges
Oncology. 2018-06-15
Journal Articles
- A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic CarcinomaBrown RJ, Murphy CD, Lisella GH, Libby AL, Njiaju UO, Rabinovitch RA, Borges VF, Oncology (Williston Park), 1/1/2016
- Pilot dietary intervention with heat-stabilized rice bran reveals modulation of microbial metabolism for intestinal health6. Amy M. Sheflin, Erica C. Borresen, Melissa J. Wdowik, Sangeeta Rao, Regina J. Brown, Adam L. Heuberger, Corey Broeckling, Elizabeth P. Ryan*, Tiffany L. Weir*, Nutrients, 1/1/2015
- Feasibility of Increased Navy Bean Powder Consumption for Primary and Secondary Colorectal Cancer Prevention Special Issue "Dietary Habits, Behaviors and Practices in...Erica C. Borresen, Kerry A. Gundlach, Melissa J. Wdowik, Regina J. Brown, and Elizabeth P. Ryan*, Current Nutrition and Food Science, 1/1/2014
- Join now to see all
Abstracts/Posters
- Breast cancer update 2006.Brown RJ, Plenary session presentation at University of Vermont,Women in Medicine Conference, Santa Fe, NM, 1/14/2006
- The feasibility and safety of intraductal administration of pegylated liposomal doxorubicin (Doxil�) in women with breast cancer. Dr. Susan Love Research Foundation 4t...Brown RJ, Breast Cancer Res, 1/1/2005
- Parathyroid hormone regulations of collagenase-3 by AP-1 factors and CBFA1 in osteoblastic and non-osteoblastic cell lines.Selvamurugan N, Brown RJ, Pulumati MR, and Partridge NC, Bone, Journal of the International Bone and Mineral Society (IBMS); American Society for Bone and Mineral Research (ASBMR)-(IBMS) Joint Meeting, San Francisco, CA, 1/1/1998
- Join now to see all
Other
- Commentary on: "Effect of screening and adjuvant therapy on mortality from breast cancer." (Berry DA, Feurer EJ et al, N Engl J Med 2005;353:1784-92).Brown RJ, Stearns V, The North American Menopausal Society (NAMS): First to Know
http://www.menopause.org/news/news1205.pdf
1/1/2005
Press Mentions
- Orangetheory Goes Pink to Prevent Breast CancerOctober 10th, 2017
- AACR: Phase Ii Trial Shows Rice Bran Promotes Microbiome Diversity, Slows Growth of Colorectal Cancer CellsApril 4th, 2017
- FDA-Approved Cooling Camp Minimizes Hair Loss During ChemotherapySeptember 21st, 2016
- Join now to see all
Committees
- Board of Directors/President-Elect, Rocky Mountain Oncology Society 2016 - Present
- Protocol Review and Monitoring System/Reviewer, Scientific Review Committee 2016 - Present
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: